Membrane Signaling Networks, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Solna, 171 76 Stockholm, Sweden.
Life Sci. 2010 Jan 16;86(3-4):73-8. doi: 10.1016/j.lfs.2009.10.019. Epub 2009 Nov 10.
Chronic hypertension is characterized by a persistent increase in vascular tone. Sodium-rich diets promote hypertension; however, the underlying molecular mechanisms are not fully understood. Variations in the sodium content of the diet, through hormonal mediators such as dopamine and angiotensin II, modulate renal tubule Na(+),K(+)-ATPase activity. Stimulation of Na(+),K(+)-ATPase activity increases sodium transport across the renal proximal tubule epithelia, promoting Na(+) retention, whereas inhibited Na(+),K(+)-ATPase activity decreases sodium transport, and thereby natriuresis. Diets rich in sodium also enhance the release of adrenal endogenous ouabain-like compounds (OLC), which inhibit Na(+),K(+)-ATPase activity, resulting in increased intracellular Na(+) and Ca(2+) concentrations in vascular smooth muscle cells, thus increasing the vascular tone, with a corresponding increase in blood pressure. The mechanisms by which these homeostatic processes are integrated in response to salt intake are complex and not completely elucidated. However, recent scientific findings provide new insights that may offer additional avenues to further explore molecular mechanisms related to normal physiology and pathophysiology of various forms of hypertension (i.e. salt-induced). Consequently, new strategies for the development of improved therapeutics and medical management of hypertension are anticipated.
慢性高血压的特征是血管张力持续增加。富含钠的饮食会促进高血压;然而,其潜在的分子机制尚未完全阐明。通过多巴胺和血管紧张素 II 等激素介质,饮食中钠含量的变化调节肾小管 Na(+),K(+)-ATP 酶活性。Na(+),K(+)-ATP 酶活性的刺激增加了肾近端小管上皮细胞的钠转运,促进钠潴留,而 Na(+),K(+)-ATP 酶活性的抑制则减少钠转运,从而导致利钠作用。富含钠的饮食还增强了肾上腺内源性哇巴因样化合物 (OLC) 的释放,后者抑制 Na(+),K(+)-ATP 酶活性,导致血管平滑肌细胞内 Na(+)和 Ca(2+)浓度增加,从而增加血管张力,相应地增加血压。这些体内平衡过程整合以响应盐摄入的机制很复杂,尚未完全阐明。然而,最近的科学发现提供了新的见解,可能为进一步探索与各种形式高血压(即盐诱导性)的正常生理学和病理生理学相关的分子机制提供了额外的途径。因此,预计将开发出改善高血压治疗和医疗管理的新策略。